Cargando…
Levosimendan Improves Clinical Outcomes of Refractory Heart Failure in Elderly Chinese Patients
BACKGROUND: Levosimendan has been extensively used to treat heart failure (HF) for nearly 10 years, but data on levosimendan used in elderly patients with refractory HF remains limited. This study aimed to investigate the effects of levosimendan on elderly patients with intractable HF. MATERIAL/METH...
Autores principales: | Zhang, Dengqing, Yao, Yuanqing, Qian, Jun, Huang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548701/ https://www.ncbi.nlm.nih.gov/pubmed/26289557 http://dx.doi.org/10.12659/MSM.893580 |
Ejemplares similares
-
Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
por: Juguet, William, et al.
Publicado: (2020) -
Efficiency and Safety of Prolonged Levosimendan Infusion in Patients with Acute Heart Failure
por: Aidonidis, Georgios, et al.
Publicado: (2011) -
Mortality reduction with levosimendan in patients with heart failure: Current evidence is underpowered
por: Sanfilippo, Filippo, et al.
Publicado: (2021) -
Use of levosimendan in acute heart failure
por: Harjola, Veli-Pekka, et al.
Publicado: (2018) -
Intermittent levosimendan infusions in advanced heart failure: a real world experience
por: Ortis, Benedetta, et al.
Publicado: (2017)